#Breaking: . @Pfizer Inc and #Germany’s @BioNTech_Group are expected to submit an emergency use authorization for #children aged six months to 5 years

.@Pfizer Inc and Germany's @BioNTech_Group are expected to submit an emergency use authorization request as early as Tuesday to the @US_FDA for #vaccines for #children aged six months to 5 years.https://t.co/q7IDaGRVzj

— The Jerusalem Post (@Jerusalem_Post) February 1, 2022

Source: Twitter